Teleflex Announces European Market Clearance for its Arrow® VPS Rhythm™ System
October 26 2016 - 6:45AM
Business Wire
CE mark for Arrow® VPS Rhythm™ System brings
cost-effective catheter navigation and tip confirmation to
Europe
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies for critical care and surgery, has announced
that its Arrow® VPS Rhythm™ System has been issued CE certification
from its notified body, the British Standards Institution (BSI), to
commercialize the device in the European Union.
The Arrow® VPS Rhythm™ System is a simple and flexible solution
that helps take the guesswork out of central catheter procedures by
providing ECG-based tip confirmation in a highly portable,
lightweight and versatile design. The Arrow® VPS Rhythm™ System
with ECG Technology assists in placement and confirmation of the
catheter tip in the SVC-CAJ (superior vena cava-cavoatrial
junction), and may be used with a broad range of catheter types.
When paired with the single-use TipTracker™ Stylet, the Arrow® VPS
Rhythm™ System provides real-time navigation, tracing the catheter
pathway with a visible blue line on a color screen. Intravascular
P-wave changes are saved as the catheter approaches the SVC,
helping to identify the lower 1/3 of the SVC, near the CAJ,
eliminating the need for confirmatory chest X-ray or
fluoroscopy.
“This clearance puts us in a position to establish a
cost-effective standard of care in catheter navigation and
placement in Europe,” commented Jay White, president and general
manager, Vascular Access Division of Teleflex. “Our goal is to make
zero complications a reality to improve outcomes and enhance
patient and provider safety.”
The Teleflex Vascular Access Division markets a broad range of
catheters for vascular access and vascular catheter management
technologies, including the Arrow® brand of devices in Europe.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® – trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA,
Pilling, Rusch, TipTracker, VPS Rhythm and Weck are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates,
in the U.S. and/or other countries. All other trademarks are
trademarks of their respective owners.© 2016 Teleflex Incorporated.
All rights reserved. MC-002777
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161026005103/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024